Jellatech develops cell based human collagen for bioprinting

Jellatech, a cellular agriculture company specializing in collagen, has successfully developed a full length, triple helical, bio-identical and functional human collagen made from their own proprietary cell line. This latest development comes just eight months after Jellatech’s showcase of cell-based bovine collagen.

Collagen is a by-product of the meat industry. It is present in skin serums, or with its derivative, gelatin, in gummy bears. This ingredient is used in a number of applications such as for food texturizers, vaccine stabilizers, pill capsules, the clarification of wine and beer, and many more. Today, the only way to source native, functional collagen is to extract it from animals. This is what Jellatech is changing by making  functional, native collagen – without animals. Cellular agriculture enables the company to produce a more sustainable, smarter high quality collagen that breaks the cycle of relying on an inefficient and unethical supply chain of live animals.

“We are extremely proud and excited to announce the expansion of our protein portfolio with human collagen. Human collagen is such an important step in our journey to make a positive impact.Stephanie Michelsen, Founder & CEO.

“This milestone further demonstrates that our platform technology for efficiently producing high-quality collagen is translatable across multiple cell types, which allows us to address a broad market need for collagen,” added Rob Schutte, Head of Science.

Human collagen is used in a wide array of biomedical and clinical applications in tissue engineering, arthritis treatment, regenerative medicine, dermal filler, 3D bioprinting, among many others.

In 2021, the company Humabiologics introduced the first native human collagen bioinks and gelatin bioinks. These bioinks were developed to be affordable and more clinically relevant, enabling researchers to advance the translational research of bioprinted human organs and tissues.

Building on Jellatech’s latest developments, the company is now looking to raise funds to scale up production and move toward commercialization. With the plethora of applications for Jellatech’s proteins, the company is also exploring partnerships, collaborations and strategic synergies to accelerate their path to providing reliable and sustainable collagen to the world.